While earlier studies described the AD-dependent relevance of cyclin-dependent kinase inhibitor 1A (CDKN1A alias p21) and STAT3 [48, 49], we found no significant differences between AD NSCs and healthy NSCs. This evidence concerns the gene STAT3 and Alzheimer disease.